M13L (p.Met13Leu) variant of PRKG1 (cGMP-dependent protein kinase 1)
M13L (p.Met13Leu) in PRKG1 (cGMP-dependent protein kinase 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes population frequency data and structural context.
M13L (p.Met13Leu) variant details
- p.Met13Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.191
- MetaLR 0.05
- MetaSVM -0.98
- CADD 15.00
- SIFT 0.29
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available